Follow the 그린생명과학 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 그린생명과학 has logged 2 reports. Market capitalisation: €42.2bn. The latest transaction was disclosed on 31 July 2026 (Purchase). Among the most active insiders: 그린케미칼. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
그린생명과학 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.